# [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

> **NCT01608009** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 16 (actual)

## Conditions studied

- Ovarian Neoplasm

## Interventions

- **DRUG:** Pazopanib and paclitaxel

## Key facts

- **NCT ID:** NCT01608009
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-05
- **Final completion:** 2016-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608009, "[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01608009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*